Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2015 Jul;94(30):e1160.
doi: 10.1097/MD.0000000000001160.

Mild Caloric Restriction Decreases Insulin Requirements in Patients With Type 2 Diabetes and Severe Insulin Resistance

Affiliations
Randomized Controlled Trial

Mild Caloric Restriction Decreases Insulin Requirements in Patients With Type 2 Diabetes and Severe Insulin Resistance

Cristina Adelia Meehan et al. Medicine (Baltimore). 2015 Jul.

Abstract

Type 2 diabetes (T2D) affects ~10% of the US population, a subset of whom have severe insulin resistance (SIR) (>200 units/d). Treatment of these patients with high-dose insulin presents logistical and compliance challenges. We hypothesized that mild caloric restriction would reduce insulin requirements in patients with T2D and SIR.This was a retrospective study at the National Institutes of Health Clinical Center. Inclusion criteria were as follows: T2D, and insulin dose >200 units/d or >2 units/kg/d. The intervention consisted of mild caloric restriction during a 3 to 6-day hospitalization. The major outcomes were change in insulin dose and blood glucose from admission to discharge.Ten patients met inclusion criteria. Baseline glycated hemoglobin A1c was 10.0 ± 1.6% and body mass index 38.8 ± 9.0 kg/m. Food intake was restricted from 2210 ± 371 kcal/d preadmission to 1810 ± 202 during the hospital stay (16.5% reduction). Insulin dose decreased from 486 ± 291 units/d preadmission to 223 ± 127 at discharge (44% reduction, P = 0.0025). Blood sugars decreased nonsignificantly in the fasting state (from 184 ± 85 to 141 ± 42, P = 0.20), before lunch (239 ± 68 to 180 ± 76, P = 0.057), and at bedtime (212 ± 95 to 176 ± 48, P = 0.19), and significantly decreased before dinner (222 ± 92 to 162 ± 70, P = 0.016).Mild caloric restriction, an accessible and affordable intervention, substantially reduced insulin doses in patients with T2D and SIR. Further studies are needed to determine if the intervention and results are sustainable outside of a hospital setting.

PubMed Disclaimer

Conflict of interest statement

There was no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.

Figures

FIGURE 1
FIGURE 1
(A) Insulin requirements before admission and after 3 to 6 days of mild caloric restriction in 10 patients with type 2 diabetes and severe insulin resistance. (B) Insulin requirements on each day of the hospitalization in the same patients (solid black lines/circles represent individual patients, dashed line/squares show the mean for all patients).
FIGURE 2
FIGURE 2
Mean (SD) capillary blood glucose in the first 24 hours after admission (black bars) versus after 3 to 6 days of mild caloric restriction (white bars) in 10 patients with type 2 diabetes and severe insulin resistance in the fasting state, prelunch, predinner, and at bedtime.
FIGURE 3
FIGURE 3
Mean (SD) capillary blood glucose on each day of the hospitalization during 3 to 6 days of mild caloric restriction in 10 patients with type 2 diabetes and severe insulin resistance in the fasting state (A), prelunch (B), predinner (C), and at bedtime (D).

References

    1. Bauman WA, Schwartz E, Rose HG, et al. Early and long-term effects of acute caloric deprivation in obese diabetic patients. Am J Med 1988; 85:38–46. - PubMed
    1. Cochran E, Musso C, Gorden P. The use of U-500 in patients with extreme insulin resistance. Diabetes Care 2005; 28:1240–1244. - PubMed
    1. Cochran EK, Valentine V, Samaan KH, et al. Practice tips and tools for the successful use of U-500 regular human insulin: the diabetes educator is key. Diabetes Educ 2014; 40:153–165. - PubMed
    1. Distiller LA, Nortje H, Wellmann H, et al. Treatment of the obese type 2 diabetes patient with severe insulin resistance: a 24-week, prospective, randomized, ppen-label, treat-to-target study: a pilot study to compare the efficacy of U-500 regular insulin plus metformin with U-500 regular insulin, metformin, and exenatide. Endocr Pract 2014; 1–26. - PubMed
    1. Gorden P, Zadeh ES, Cochran E, et al. Syndromic insulin resistance: models for the therapeutic basis of the metabolic syndrome and other targets of insulin resistance. Endocr Pract 2012; 18:763–771. - PMC - PubMed

Publication types

MeSH terms